Organ Preservation Solutions Market surpassed US$ 225 Mn in 2021, owing to rising number of organ transplant and organ donors | insightSLICE
The global Organ Preservation Solutions market size was estimated to be US$ 225 million in 2021 and is expected grow at a CAGR of 9% between 2023 to 2032.
The main drivers propelling the development of the worldwide organ preservation solution market are growing organ failure rates, increased public awareness of organ donation, and improvements in healthcare equipment related to organ transplantation.
The organs are preserved using organ preservation techniques up to transplantation. With the use of impermeant substances such as lactobionic acid, raffinose, and hydroxyethyl starch, organ preservation preparations inhibit the swelling of organ cells during cold storage.
Access the sample report: https://www.insightslice.com/request-sample/342
The main use of organ preservation techniques is the rise in demand for kidney transplants during the past ten years. The Health Resources & Services Administration reported that 23,401 kidney transplants were carried out in the United States alone in 2019.
Furthermore, it is predicted that increased global awareness of organ donation would lead to a growth in the number of yearly transplant surgeries, driving demand for the organ preservation solutions market during the projection period.
The key players of the Global Organ Preservation Solutions Market are:
Accord Healthcare, BioLife Solutions, Inc., Bridge to Life Ltd., Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion AB., Teva Pharmaceutical Industries Ltd., 21st Century Medicine, Bristol-Myers Squibb Company, OrganOx Limited, and others are significant companies in the global market for organ preservation solutions.
Organ Preservation Solutions Market report and its key features:
The Organ Preservation Solutions Market report for the years 2022 to 2032 will cover topics like global market share, trends, and forecasts. In this report, the years up to 2020 as historic records, the year 2021 serves as the base year and the years from 2022 to 2032 are the forecast period, respectively.
Our research takes into account the competition environment, and the report will include an analysis of the major companies in the worldwide myasthenia gravis therapy market as well as their market forecasts.
In addition, the report will provide information on important advancements, worldwide and regional sales networks, business strategies, research and development initiatives, staff strength, and key executives for all significant players in the Organ Preservation Solutions Market.
Read more about the report inclusions: https://www.insightslice.com/organ-preservation-solutions-market
The report includes an in-depth analysis of key competitors with a controlling stake in the worldwide market with an emphasis on all functioning business segments and therefore would define the company segment concentrating on organ preservation solutions.
Additionally, market shares of well-known businesses in the market for organ preservation solutions globally would be calculated. The analysis takes into account the essential competitive data, including corporate strategy, product offerings, recent changes, SWOT analysis, and research and advancement objectives of all the organ preservation solutions providers.
The participants involved in the market’s supply chain and value chain, as well as their contributions, will also be taken into account in the research of the global market for organ preservation solutions. The company’s organ preservation solutions business segment’s whole product line would be the focus of the product portfolio.
Comparable to this, the current development portion would concentrate on the most recent firm developments, including regional growth, mergers and acquisitions, the introduction of new products, and bilateral agreements and collaborations in the market for global organ preservation solutions.
Regional performance of Organ Preservation Solutions Market
Due to the growing number of organ donors and the rise in organ transplantation, North America accounted for the biggest share of the worldwide market for organ preservation solutions in 2019 and is expected to continue to hold this position during the projected period.
According to data from the Health Resources & Services Administration, there were 112,568 people awaiting organ transplants in the United States in 2019. Due to the rising number of active donors in the nation, the waiting list has been declining since 2013 and is expected to continue to do so.
Due to an increase in organ transplant procedures, the demand for solutions for organ preservation is anticipated to increase in the upcoming years.
Due to rising organ failure rates brought on by chronic illnesses, increased consciousness about organ donation, and expanding healthcare infrastructure, Asia Pacific is anticipated to be a lucrative market in the years to come.
Global Clinical Trial Materials and Supplies Market: https://www.insightslice.com/clinical-trial-materials-and-supplies-market
Global Brain Computer Interface Market: https://www.insightslice.com/brain-computer-interface-market
Global Organ Preservation Solutions Market Key Segments:
- Custodiol HTK
- siRNA Transplant Solutions
- HBS Solution
By Preservation Technique
- Hypothermic Perfusion Preservation
- Static Cold Storage
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Rest of South America
Proceed to purchase: https://www.insightslice.com/buy-now/342
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at firstname.lastname@example.org.
+1 707 736 6633